1,122
Participants
Start Date
July 29, 2019
Primary Completion Date
December 11, 2020
Study Completion Date
December 11, 2020
Insulin Degludec/Insulin Aspart
Insulin Degludec/Insulin Aspart (Ryzodeg®) as prescribed by the patient's treating physician. The decision to initiate or switch into treatment with commercially available Ryzodeg® has been made before, and independently from, the decision to include the patient in this study.
University of Santo Tomas, Manila
St. Luke's Medical Center, Quezon City
Makati Medical Center, Makati City
Union Hospital, Alberton
Hemant Makan, Johannesburg
Dr Moosa's Rooms, Lenasia
Royal North Shore Hospital, St Leonards
Illawarra Diabetes Service Clinical Trials & Research Unit, Wollongong
Baker IDI Heart and Diabetes Institute, Melbourne
Box Hill Specialist Consulting rooms, Box Hill
Royal Brisbane and Women's Hospital, Herston
Dr H Bacus, Berea
Mater Hospital Brisbane, South Brisbane
Iloilo Diabetes Care Center, Iloilo City
South Australian Endocrine Research, Keswick
Lyell McEwin Hospital, Elizabeth Vale
Greenacres Hospital, Port Elizabeth
Netcare Greenacres Hospital, Port Elizabeth
Rockingham General Hospital, Cooloongup
ProHealth Wellness Centre, Port Elizabeth
Hobart Cardiology, Hobart
Davao Doctors Hospital, Davao City
Medi-Clinic Bloemfontein, Bloemfontein
Island Hospital, George Town
Specialized medical center, Riyadh
Riyadh Care Hospital, Riyadh
National Guard Hospital, Riyadh
Dallah Hospital, Riyadh
Kota Bahru Medical Centre Sdn Bhd, Kelantan
Hospital Universiti Sains Malaysia, Kota Bharu, Kelantan
King Abdulaziz University Hospital, Jeddah
Dr Bakhsh Hospital, Jeddah
Dr. Ghassan N. Faroun Hospital, Jeddah
Saudi German Hospital, Jeddah
Umm Alquara University Hospital, Mecca
Klinik Chong, Perak
Subang Jaya Medical Center, Kuala Selangor
Thomson Hospital, Kuala Selangor
Gleneagles Hospital, Kuala Lumpur
Hospital Putrajaya, Putrajaya
Mahkota Medical Center, Malacca
Pantai Hospital Ayer Keroh, Malacca
Borneo Medical Centre, Kuching
KPJ Kuching, Kuching
Max Super Speciality Shalimar Bhagh, Delhi
Fortis Hospital, New Delhi
Fortis Heart Institute and Multispeciality Hospital, Mohali
DEW Medicare & Trinity hospital, Nagpur
Columbia Asia Hospital, Bangalore
Pace Diabetes Center, Bangalore
R.M. Diabetes Education & Research Foundation, Chennai
Narayana Superspeciality Hospital, Howrah
AMRI Hospital, Bhubaneswar
Excelcare Hospital, Guwahati
Remedic Clinic, Kangar
Pantai Hospital, Kedah
Panay Healthcare Medical Center, Aklan
Perpetual Succor Hospital, Cebu City
Manila Doctor's Hospital, Manila
University of Sto. Tomas Hospital, Manila
Providence Hospital, Quezon City
University of the East-Ramon Magsaysay Memorial Medical Ctr, Quezon City
My clinic, Jeddah
Prof P. Joshi, Pretoria
Lead Sponsor
Novo Nordisk A/S
INDUSTRY